Administration of resveratrol: What formulation solutions to bioavailability limitations?
about
Plant-derived anti-inflammatory compounds: hopes and disappointments regarding the translation of preclinical knowledge into clinical progressPiceatannol, natural polyphenolic stilbene, inhibits adipogenesis via modulation of mitotic clonal expansion and insulin receptor-dependent insulin signaling in early phase of differentiationResveratrol and clinical trials: the crossroad from in vitro studies to human evidenceResveratrol and Ophthalmic DiseasesInteractions between CYP3A4 and Dietary PolyphenolsPolyphenol Stilbenes: Molecular Mechanisms of Defence against Oxidative Stress and Aging-Related DiseasesDietary Antioxidants as Modifiers of Physiologic Adaptations to ExerciseResveratrol treatment reduces cardiac progenitor cell dysfunction and prevents morpho-functional ventricular remodeling in type-1 diabetic ratsDietary Phytochemicals in Neuroimmunoaging: A New Therapeutic Possibility for Humans?Resveratrol inhibits LPS-induced MAPKs activation via activation of the phosphatidylinositol 3-kinase pathway in murine RAW 264.7 macrophage cellsStilbene induced inhibition of androgen receptor dimerization: implications for AR and ARΔLBD-signalling in human prostate cancer cellsUse of In Vitro and Predictive In Silico Models to Study the Inhibition of Cytochrome P4503A by StilbenesResveratrol Reverses Functional Chagas Heart Disease in MiceEffect of lipolysis on drug release from self-microemulsifying drug delivery systems (SMEDDS) with different core/shell drug location.Resveratrol as a therapeutic agent for Alzheimer's disease.Preparation and optimization of resveratrol nanosuspensions by antisolvent precipitation using Box-Behnken designAnti-proliferative and gene expression actions of resveratrol in breast cancer cells in vitroTargeted intracellular delivery of resveratrol to glioblastoma cells using apolipoprotein E-containing reconstituted HDL as a nanovehicle.Resveratrol Antagonizes Antimicrobial Lethality and Stimulates Recovery of Bacterial Mutants.Folic acid-functionalized drug delivery platform of resveratrol based on Pluronic 127/D-α-tocopheryl polyethylene glycol 1000 succinate mixed micellesCritical review of resveratrol in xenobiotic-induced hepatotoxicity.Chronic resveratrol reverses a mild angiotensin II-induced pressor effect in a rat model.Nanoscale Delivery of Resveratrol towards Enhancement of Supplements and NutraceuticalsBrain-targeted delivery of resveratrol using solid lipid nanoparticles functionalized with apolipoprotein E.Protein folding and aggregation into amyloid: the interference by natural phenolic compoundsInhibition of cytochrome P450 3A by acetoxylated analogues of resveratrol in in vitro and in silico models.Nanoformulation of natural products for prevention and therapy of prostate cancer.Sinonasal Delivery of Resveratrol via Mucoadhesive Nanostructured Microparticles in a Nasal Polyp Mouse Model.Resveratrol, Potential Therapeutic Interest in Joint Disorders: A Critical Narrative Review.Resveratrol improves motoneuron function and extends survival in SOD1(G93A) ALS mice.Resveratrol biosynthesis: plant metabolic engineering for nutritional improvement of food.Sirtuin deacetylases in neurodegenerative diseases of aging.Nano- and micro-encapsulated systems for enhancing the delivery of resveratrol.The application of nanosponges to cancer drug delivery.Neuroprotective effects of resveratrol in Alzheimer disease pathology.Enhancing the delivery of resveratrol in humans: if low bioavailability is the problem, what is the solution?Resveratrol supplementation: Where are we now and where should we go?Resveratrol nanoformulation for cancer prevention and therapy.Therapeutic potential of resveratrol in heart failure.Significance of Resveratrol in Clinical Management of Chronic Diseases.
P2860
Q21284734-719EFCBB-9B3D-4045-9A23-C9EDD24692E4Q24600155-B65BBB5F-B0E0-49E0-8632-4D2E1B3AE94BQ24618313-E06E85CE-9E61-45E6-B0D4-D55E97466ACEQ26750615-40FAA4B6-1975-40AE-B3E4-8E614EFD469CQ26800893-29CF7A05-2CCD-41E1-A8BA-DC05B95A7539Q26800956-6A0D9EE1-2208-4439-B0B1-973F90E5710BQ26825013-22523B56-3538-4389-9485-E19ED656C42AQ27300198-4CD7208F-05F9-4B17-9679-F367EFC2F625Q28075814-C64BF192-9E9E-4161-B2F0-3FE8AA9E8A6BQ28483244-7982B134-B390-4132-B0E7-E0067A2B0CA7Q28539233-AAC05523-4B64-47AC-B7AF-A2E25299C93BQ28550408-7C56DB4B-BFFB-4C64-B25C-D977463B030BQ28553008-E404D89B-8240-4DF6-8EA6-D9CF27B8419DQ33681221-4E95B6E1-4014-4415-BB4E-72AC932F1E5CQ34667472-98417CAD-345D-4C00-888A-E4789185D2F2Q35024394-D888321C-960C-4853-BCDD-E5ED1A55AEE1Q35149578-D1C1207C-23A4-45A7-9D6E-E38BD85F433DQ35741305-96413563-B35E-4355-9482-828603969ACEQ35979673-BA693271-6761-4376-A1D2-8E1218932DBFQ36341468-0ACBAAC2-C72F-42CF-81A0-A1EC87B80EE9Q36454762-8CB1F7B1-3325-44FB-AC40-9B831B2751A2Q36525791-2ABE6442-E9EE-4374-BA66-3A6435695468Q36732033-2FAD976F-119C-4EA2-B132-BD719473CD6AQ36783549-19C8FFF9-637A-4D2A-976C-7E24EA519831Q37007345-0022BBD6-57F1-4C7E-98B5-4CF4221FE3EAQ37181532-0D2B7BA1-E121-4549-9313-AE584D016810Q37473193-B4E47223-1234-4CFC-A68D-FDB081E4BFBAQ37575958-1A94C01B-09B7-4344-9FA1-B2A8EAAEA81BQ37628401-C5FFBE71-1144-4E94-A3FB-7BF77390A16AQ37717433-EEC7A885-37D2-4D31-A57A-BC498740FB60Q38025006-12216CB1-0DE8-4949-A070-D48A72ADB82AQ38108128-96B26421-08C5-4673-B7E2-BD0D2CE23BBCQ38121603-35759CFC-AA13-4FD9-AE80-52111F3B1364Q38210423-181E5165-9342-4BDA-8FEC-F68CC88F1D5DQ38259550-E81ADBE6-B12F-49A2-8D26-3D20D9C18135Q38262965-0F1A9679-CDE7-4BB9-BFE9-2492E47AA58BQ38334249-05633D91-2918-4860-B88A-DF7CE5931804Q38537318-F677C17C-227F-4FE4-BB8E-952757EDF270Q38552981-55DE92A2-107F-4155-BF72-A906D5B91B4AQ38618547-C035DEF8-BF71-4013-A89F-C39CC5D80B0E
P2860
Administration of resveratrol: What formulation solutions to bioavailability limitations?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Administration of resveratrol: What formulation solutions to bioavailability limitations?
@en
Administration of resveratrol: What formulation solutions to bioavailability limitations?
@nl
type
label
Administration of resveratrol: What formulation solutions to bioavailability limitations?
@en
Administration of resveratrol: What formulation solutions to bioavailability limitations?
@nl
prefLabel
Administration of resveratrol: What formulation solutions to bioavailability limitations?
@en
Administration of resveratrol: What formulation solutions to bioavailability limitations?
@nl
P2093
P1476
Administration of resveratrol: What formulation solutions to bioavailability limitations?
@en
P2093
P304
P356
10.1016/J.JCONREL.2011.09.083
P407
P577
2011-09-25T00:00:00Z